Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition. (Q53608648)

16 May 2018

title

Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition. (English)

1 reference

16 May 2018

1 reference

Harris RA

1

1 reference

16 May 2018

Kuppermann M

series ordinal

2

1 reference

16 May 2018

Richter JE

series ordinal

3

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

16 May 2018

American Journal of Medicine

published in

1 reference

16 May 2018

volume

102

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

78-88

1 reference

16 May 2018

Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Surgery for reflux disease: reflections of a gastroenterologist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Medical therapy for gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Omeprazole versus ranitidine in erosive oesophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

7 January 2021

Acid-reflux disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

The Markov process in medical prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

The distinction between cost and charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Principles of cost-effective resource allocation in health care organizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Cost-effectiveness league tables: More harm than good?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Assessing the cost-effectiveness of medical treatments in acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

7 January 2021

inferred from DOI database lookup

Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

7 January 2021

inferred from DOI database lookup

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900301-4

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0002-9343(96)00301-4

1 reference

16 May 2018

release_xrtikdwjbnhxfdrcn74oh75tc4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xrtikdwjbnhxfdrcn74oh75tc4

24 November 2022

mapped directly with Wikidata item

1 reference

16 May 2018